Calvisi D - Search Results

1

The RASSF1A tumor suppressor activates Bax via MOAP-1.

Vos MD, Dallol A, Eckfeld K, Allen NP, Donninger H, Hesson LB, Calvisi D, Latif F, Clark GJ. Vos MD, et al. Among authors: calvisi d. J Biol Chem. 2006 Feb 24;281(8):4557-63. doi: 10.1074/jbc.M512128200. Epub 2005 Dec 12. J Biol Chem. 2006. PMID: 16344548 Free article.

2

NORE1A tumor suppressor candidate modulates p21CIP1 via p53.

Calvisi DF, Donninger H, Vos MD, Birrer MJ, Gordon L, Leaner V, Clark GJ. Calvisi DF, et al. Cancer Res. 2009 Jun 1;69(11):4629-37. doi: 10.1158/0008-5472.CAN-08-3672. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435914 Free PMC article.

3

NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.

Donninger H, Calvisi DF, Barnoud T, Clark J, Schmidt ML, Vos MD, Clark GJ. Donninger H, et al. Among authors: calvisi df. J Cell Biol. 2015 Mar 16;208(6):777-89. doi: 10.1083/jcb.201408087. J Cell Biol. 2015. PMID: 25778922 Free PMC article.

4

NORE1A Regulates MDM2 Via β-TrCP.

Schmidt ML, Calvisi DF, Clark GJ. Schmidt ML, et al. Cancers (Basel). 2016 Mar 23;8(4):39. doi: 10.3390/cancers8040039. Cancers (Basel). 2016. PMID: 27023610 Free PMC article.

5

Nonstructural protein 5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication.

Arora P, Basu A, Schmidt ML, Clark GJ, Donninger H, Nichols DB, Calvisi DF, Kaushik-Basu N. Arora P, et al. Hepatology. 2017 May;65(5):1462-1477. doi: 10.1002/hep.29049. Epub 2017 Mar 30. Hepatology. 2017. PMID: 28090674 Free PMC article.

6

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

Calvisi DF, Ladu S, Gorden A, Farina M, Conner EA, Lee JS, Factor VM, Thorgeirsson SS. Calvisi DF, et al. Gastroenterology. 2006 Apr;130(4):1117-28. doi: 10.1053/j.gastro.2006.01.006. Gastroenterology. 2006. PMID: 16618406

7

Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.

Calvisi DF, Ladu S, Gorden A, Farina M, Lee JS, Conner EA, Schroeder I, Factor VM, Thorgeirsson SS. Calvisi DF, et al. J Clin Invest. 2007 Sep;117(9):2713-22. doi: 10.1172/JCI31457. J Clin Invest. 2007. PMID: 17717605 Free PMC article.

8

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.

Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS. Lee JS, et al. Nat Med. 2006 Apr;12(4):410-6. doi: 10.1038/nm1377. Epub 2006 Mar 12. Nat Med. 2006. PMID: 16532004

9

Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis.

Hironaka K, Factor VM, Calvisi DF, Conner EA, Thorgeirsson SS. Hironaka K, et al. Lab Invest. 2003 May;83(5):643-54. doi: 10.1097/01.lab.0000067483.89649.11. Lab Invest. 2003. PMID: 12746474 Free article.

10

E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer.

Ladu S, Calvisi DF, Conner EA, Farina M, Factor VM, Thorgeirsson SS. Ladu S, et al. Gastroenterology. 2008 Oct;135(4):1322-32. doi: 10.1053/j.gastro.2008.07.012. Epub 2008 Jul 17. Gastroenterology. 2008. PMID: 18722373 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page